BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 27028715)

  • 1. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice.
    Peng J; Hui K; Hao C; Peng Z; Gao QX; Jin Q; Lei G; Min J; Qi Z; Bo C; Dong QN; Bing ZH; Jia XY; Fu DL
    Connect Tissue Res; 2016 Jul; 57(4):277-89. PubMed ID: 27028715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
    Coe LM; Zhang J; McCabe LR
    J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.
    Peng J; Lai ZG; Fang ZL; Xing S; Hui K; Hao C; Jin Q; Qi Z; Shen WJ; Dong QN; Bing ZH; Fu DL
    PLoS One; 2014; 9(11):e112744. PubMed ID: 25394221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of type H vessels by NOX2-mediated endothelial oxidative stress: critical mechanisms and therapeutic targets for bone fragility in streptozotocin-induced type 1 diabetic mice.
    Hu XF; Xiang G; Wang TJ; Ma YB; Zhang Y; Yan YB; Zhao X; Wu ZX; Feng YF; Lei W
    Theranostics; 2021; 11(8):3796-3812. PubMed ID: 33664862
    [No Abstract]   [Full Text] [Related]  

  • 5. Deletion of FoxO1, 3, and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes.
    Iyer S; Han L; Ambrogini E; Yavropoulou M; Fowlkes J; Manolagas SC; Almeida M
    J Bone Miner Res; 2017 Jan; 32(1):60-69. PubMed ID: 27491024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice.
    Ham JR; Choi RY; Lee HI; Lee MK
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
    Zhang Y; Li XL; Sha NN; Shu B; Zhao YJ; Wang XL; Xiao HH; Shi Q; Wong MS; Wang YJ
    Bone; 2017 Apr; 97():222-232. PubMed ID: 28130181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
    Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
    Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes.
    Cao Y; Han X; Wang Z; Liu Y; Wang Y; Zhang R; Ye J; Zou L; Dai W
    Biochem Biophys Res Commun; 2021 Mar; 546():185-191. PubMed ID: 33601314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of nitric oxide in type 1 diabetes-induced osteoporosis.
    Jeddi S; Yousefzadeh N; Kashfi K; Ghasemi A
    Biochem Pharmacol; 2022 Mar; 197():114888. PubMed ID: 34968494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/enhancer binding protein β-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption.
    Motyl KJ; Raetz M; Tekalur SA; Schwartz RC; McCabe LR
    Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1250-60. PubMed ID: 21346244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption.
    Nakamura M; Udagawa N; Matsuura S; Mogi M; Nakamura H; Horiuchi H; Saito N; Hiraoka BY; Kobayashi Y; Takaoka K; Ozawa H; Miyazawa H; Takahashi N
    Endocrinology; 2003 Dec; 144(12):5441-9. PubMed ID: 14500574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss.
    Zhao Q; Shen X; Zhang W; Zhu G; Qi J; Deng L
    Bone; 2012 Mar; 50(3):763-70. PubMed ID: 22193550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High fat diet attenuates hyperglycemia, body composition changes, and bone loss in male streptozotocin-induced type 1 diabetic mice.
    Carvalho AL; DeMambro VE; Guntur AR; Le P; Nagano K; Baron R; de Paula FJA; Motyl KJ
    J Cell Physiol; 2018 Feb; 233(2):1585-1600. PubMed ID: 28631813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.
    Kalaitzoglou E; Popescu I; Bunn RC; Fowlkes JL; Thrailkill KM
    Curr Osteoporos Rep; 2016 Dec; 14(6):310-319. PubMed ID: 27704393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endoplasmic reticulum stress in disuse osteoporosis.
    Li J; Yang S; Li X; Liu D; Wang Z; Guo J; Tan N; Gao Z; Zhao X; Zhang J; Gou F; Yokota H; Zhang P
    Bone; 2017 Apr; 97():2-14. PubMed ID: 27989543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
    Baud'huin M; Solban N; Cornwall-Brady M; Sako D; Kawamoto Y; Liharska K; Lath D; Bouxsein ML; Underwood KW; Ucran J; Kumar R; Pobre E; Grinberg A; Seehra J; Canalis E; Pearsall RS; Croucher PI
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12207-12. PubMed ID: 22761317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.
    Motyl KJ; McCauley LK; McCabe LR
    J Cell Physiol; 2012 Apr; 227(4):1326-34. PubMed ID: 21604269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.